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Background: The prevalence of coexisting chronic conditions (multimorbidity) is rising. Disease labels, however,
give little information about impact on subjective health and personal illness experience. We aim to examine the
strength of association of single and multimorbid physical chronic diseases with self-rated health in a middle-aged
and older population in England, and to determine whether any association is mediated by depression and other
psychosocial factors.
Methods: 25 268 individuals aged 39 to 79 years recruited from general practice registers in the European Prospective
Investigation of Cancer (EPIC-Norfolk) study, completed a survey including self-rated health, psychosocial function and
presence of common physical chronic conditions (cancer, stroke, heart attack, diabetes, asthma/bronchitis and arthritis).
Logistic regression models determined odds of “moderate/poor” compared to “good/excellent” health by condition
and number of conditions adjusting for psychosocial measures.
Results: One-third (8252) reported one, around 7.5% (1899) two, and around 1% (194) three or more conditions. Odds
of “moderate/poor” self-rated health worsened with increasing number of conditions (one (OR = 1.3(1.2–1.4)) versus
three or more (OR = 3.4(2.3–5.1)), and were highest where there was comorbidity with stroke (OR = 8.7(4.6–16.7)) or
heart attack (OR = 8.5(5.3–13.6)). Psychosocial measures did not explain the association between chronic diseases and
multimorbidity with self-rated health.The relationship of multimorbidity with self-rated health was particularly strong in
men compared to women (three or more conditions: men (OR = 5.2(3.0–8.9)), women OR = 2.1(1.1–3.9)).
Conclusions: Self-rated health provides a simple, integrative patient-centred assessment for evaluation of illness in the
context of multiple chronic disease diagnoses. Those registering in general practice in particular men with three or
more diseases or those with cardiovascular comorbidities and with poorer self-rated health may warrant further
assessment and intervention to improve their physical and subjective health.
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As populations in developed countries age, so the num-
ber with single and multiple chronic conditions is in-
creasing [1]. In recent international studies up to 50%
of those with one chronic disease diagnosis have one or
more other diagnoses; known as “multimorbidity”,* Correspondence: nm212@medschl.cam.ac.uk
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Patients with multimorbidity suffer more, have poorer
health outcomes including increased complications and
earlier death, and require greater access to and use of
primary and secondary health care than those with sin-
gle conditions [6-12]. Tools are needed to enable inte-
grative assessment of the impact of multimorbidity on
patients so that services may be focussed according to
individual need [13-15]. Available tools range from sim-
ple disease counts to standardized measures such asral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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Charlson index (Charlson) and the Functional Comor-
bidity Index (FCI) [16-18]. While the latter are complex
and designed for epidemiological rather than practice
use, simple disease counts have shown to be valid and
offer an intuitive approach to measurement [19-21].
For the clinic, however, a simple summary measure of
individual health impact is needed which is easily meas-
urable and reflects the illness experience of the patient
with a number of chronic diseases.
Self-rated health (SRH) is elicited through a single
question and could efficiently complement and individu-
alise the count of common chronic diseases currently
obtainable from General Practice records. It has been
widely validated in epidemiological studies, reflects the
subjective experience of health associated with more
complex measures of health-related quality of life, and
independently predicts health outcomes including all-
cause mortality, disease specific mortality, morbidity and
health service utilisation [22-26].
The presence of multimorbidity has been associated
in previous studies with poor SRH [27-29]. However,
what underlies this relationship has not been fully
explored. For example, it is uncertain whether it may
be predominantly psychological or social factors that
mostly mediate the association of multimorbidity with
SRH, or whether the association mostly reflects the
physical dimensions of comorbid disease. The relation-
ship between mental health, multimorbidity and SRH is
complex. Mental health problems and psychosocial dif-
ficulties such as depression are often commonly comor-
bid with single or multiple chronic physical diseases
[30-33]. The presence of poor psychosocial health in
the context of chronic disease is also associated with
worse subjective health assessment [31]. In a recent
study, the comorbid state of depression with chronic
physical diseases was associated with worse subjective
health assessment than having depression alone or hav-
ing any of a range of chronic diseases alone or in com-
bination without depression [31]. The association of
multimorbidity with depression may itself be mediated
by a patients’ poor self-perceived health [30]. Previous
work in the EPIC-Norfolk and other cohorts also con-
firms a strong relationship between SRH, mental health
and social factors [34,35]. Multimorbidity particularly
involving mental health disorders, is for example, espe-
cially increased in the context of social deprivation
[32,33]. Further study is required to understand how
multimorbidity and in particular specific disease combi-
nations may impact on patients’ health experiences,
and whether such experiences are mediated by modifi-
able psychosocial factors [19,20,36]. Identifying disease
combinations leading to poorer SRH would also focus
attention on those needing most help [37].In this study, we aimed to explore the association be-
tween a number of common chronic physical condi-
tions (heart disease, diabetes, arthritis, chronic lower
respiratory tract disease and stroke) both as single and
multimorbid conditions with SRH, assessing for the
mediating effects of psychosocial function using data
from a large well-characterised population derived from
GP registers [38].
Methods
Study population
The study population comes from EPIC-Norfolk (Norfolk
component of the European Prospective Investigation of
Cancer) recruiting from general practice age-sex registers
in Norwich city and surrounding towns and country
(1993–1997) [39]. Ethical approval was obtained from the
Norfolk Local Research Ethics Committee. Invitations
were sent to all 39–79 year olds on the list of collaborating
general practitioners. Over 30,000 of 77,630 (approxi-
mately 40%) of those approached returned a consent form
indicating that they wished to join the study. Of these, 25
639 men and women aged 39–79 years attended a health
examination, gave informed signed consent and com-
pleted a baseline detailed health and lifestyle question-
naire. Detailed descriptions of the study methodology
have been reported [38]. This cohort is comparable to
other national samples with respect to physical and psy-
chosocial characteristics [38,40,41].
This cross-sectional analysis used both baseline data
and additional psychological measures which were ob-
tained at a later date by questionnaire (approximately
18 months later with a response rate of 17,268 (67%)).
371 individuals with missing data were excluded.
Measures
The health questionnaire included the single-item SRH
measure which asks: “In general, would you say your
health is?” with response options “excellent”, “good”,
“moderate” or “poor”.
Diagnoses of chronic medical conditions were deter-
mined by asking: “Has a doctor ever told you that you
have any of the following?” followed by a list of options
including cancer, stroke, heart attack, diabetes, respira-
tory disease (asthma or bronchitis) and arthritis. Self-
reports of a previous diagnosis of depression as well as
current antidepressant use (used as a proxy for current
depression), were also elicited. Other psychosocial pa-
rameters were Emotional and Social Role Functioning
subscales and Mental subscale of the Short-form SF-36
Health Survey [42], and short form of the Neuroticism
scale of the Eysenck Personality Questionnaire (EPQ)
[43], both validated questionnaires.
Social class was collected based on self-report and
classified according to the Registrar General’s occupation
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manual) and manual classes (III manual, IV and V) [44].
Statistical analyses
Analyses used STATA statistical software version 11.0.
The analysis is stratified by gender, since men and women
may respond differently to the SRH question [45].
Descriptive statistics included means and percentages.
Differences by SRH categories in age, social class,
chronic conditions and psychological measures were
investigated. Two sample t-tests were used to compare
differences in mean values between age categories, social
class, chronic conditions and psychological measures.
Assumption of equal variances was verified. Differences
in percentages were compared using χ2-tests.
Univariate and multivariate logistic regressions models
were constructed with SRH as a dependent variable to
determine the odds of “moderate/poor” compared to
“good/excellent” SRH for chronic conditions, psycho-
social parameters, and for number of chronic conditions
adjusting for age and social class.
Number of morbidities was calculated as a count of
self-reported medical conditions: 0, 1, 2 and 3 or more.
Multimorbidity was defined as the presence of two or
more conditions. Since the focus of our research was
the impact of physical disease on self-reported health
status with mental health as a potential mediator, de-
pression was not used in the count of conditions but as
a covariate along with other measures of psychological
and social functioning. Since any self-reported depression
alone is also likely to be an underestimate of true psycho-
logical dysfunction in primary care patients, we also
included separately in our model measures of psychosocial
impairment mental health, emotional and social function-
ing and neuroticism, and antidepressant use. The 50th
centile of scores for each of the Mental Health, Role Emo-
tional and Social Functioning subscales of the SF-36, and
the Neuroticism scale were determined and scores dichot-
omised into equal and above or below the median. Anti-
depressant use was dichotomized into yes or no.
A further co-morbidity model was constructed to deter-
mine the odds of “moderate/poor” compared to “good/ex-
cellent” SRH for each chronic condition as an index
condition plus any one or more other conditions adjusted
for age, social class depression and anti-depressant use.
Results
Mean age was 59 years. 8252 (33%) reported one and
2093 (8%) more than one chronic condition. 20,101
(79.6%) rated their health as good or excellent and 5167
(20.4%) as moderate or poor (Table 1). 1,386 (5.5%)
reported antidepressant use.
Frequency of “moderate/poor” SRH rose with greater
age, lower social class, and indices of poor mental healthacross genders (Tables 2 and 3), but was not significantly
different between the genders. Frequency of “moderate/
poor” SRH also rose with the number of chronic condi-
tions and was highest in those with stroke, heart attack
and diabetes. However, even in these conditions, a minor-
ity reported excellent health. We tested the interaction
between sex and multimorbidity in the association with
SRH and found it to be significant (p-values of inter-
action term: one condition; 0.05, two conditions; <0.01,
three or more conditions; <0.01), with men having a
steeper rise in “moderate/poor” SRH with number of
conditions, and being more likely to report “moderate/
poor” SRH with stroke (p = .007).
Table 4 demonstrates the relationships between psy-
chosocial measures, chronic disease and SRH. In men,
poor scores on the SF-36 Social Functioning scale were
more strongly associated with “moderate/poor” SRH
than having a heart attack; and SF-36 Mental Health
scores and antidepressant use than with having a stroke
or diabetes. In women, SF-36 Social Functioning and
Mental Health and antidepressant use were more
strongly associated with SRH than having a stroke or
diabetes but not with having had a heart attack. Adjust-
ment for psychosocial measures reduced the odds of
“moderate/poor” SRH in those with stroke. Odds of
reporting “moderate/poor” SRH increased with the num-
ber of conditions in both men and women, but the
strength of the association was greater for men (2 condi-
tions: OR 2.1 (1.8-2.5); 3 or more conditions: OR 5.8 (3.9-
8.5)) than for women (2 conditions: OR 1.5 (1.3-1.8); 3 or
more conditions: OR 2.2 (1.4-3.6)). Adjustment for psy-
chosocial measures did not significantly reduce the odds
of poor SRH in those with multimorbid conditions.
The odds of reporting “moderate/poor” SRH in those
with two or more conditions in addition to any index
condition was also roughly twice that of reporting only
one other condition, even among the less common con-
ditions where confidence intervals were wider (Table 5,
Figure 1). Combinations with stroke and two or more
conditions in men had the highest odds of “moderate/
poor” SRH (OR 13.0 (5.4–31.1)), followed by combina-
tions of two or more conditions with heart attack (OR
10.3(5.9–18.0)) and with diabetes (OR 9.4 (5.0–17.6)).
The relationship between SRH and combinations of con-
ditions was not significantly altered by correcting for
self-reported depression and current antidepressant use.
Discussion
Summary of main findings
In this large middle-aged to older population, poorer
subjective health in the form of SRH is strongly associ-
ated with single chronic physical conditions (particu-
larly cardiovascular diseases: heart attack, stroke and
diabetes), and multiple morbidities (particularly three or
Table 1 Demographic data, chronic conditions, number of conditions, psychological measures and self-rated health in
EPIC-Norfolk
Men Women Combined
n = 11,439 n = 13,829 n = 25,268
Age (yrs) 59.1 (9.3) 58.4 (9.3) 58.7 (9.3)
Social Class
Manual 4670 (41.5) 5195 (38.5) 9865 (39.9)
Non-manual 6579 (58.5) 8290 (61.5) 14869 (60.1)
Chronic conditions
Cancer 426 (3.7) 942 (6.8) 1368 (5.4)
Stroke 202 (1.8) 140 (1.0) 342 (1.4)
Heart attack 588 (5.1) 178 (1.3) 766 (3.0)
Diabetes 357 (3.1) 214 (1.5) 571 (2.3)
Arthritis 2619 (22.9) 3143 (22.7) 5762 (22.8)
Respiratory (asthma or bronchitis) 1681 (14.7) 2163 (15.6) 3844 (15.2)
Number of reported conditions
None 6694 (58.5) 8229 (59.5) 14923 (59.1)
One 3739 (32.7) 4513 (32.6) 8252 (32.7)
Two 896 (7.8) 1003 (7.3) 1899 (7.5)
Three or more 110 (1.0) 84 (0.6) 194 (0.8)
Self-rated health
Excellent 1981 (17.3) 2139 (15.5) 4120 (16.3)
Good 7146 (62.5) 8835 (63.9) 15981 (63.2)
Moderate 2093 (18.3) 2613 (18.9) 4706 (18.6)
Poor 219 (1.9) 242 (1.7) 461 (1.8)
Psychological measures
Self-reported depression% 1509 (13.2) 1987 (14.4) 3496 (13.8)
Antidepressant use% 421 (3.7) 965 (7.0) 1,386 (5.5)
SF-36 Mental health (0–100) 79.0 (15.7) 75.8 (16.4) 77.2 (16.2)
SF-36 Role emotional (0–100) 85.5 (30.3) 82.2 (32.9) 83.7 (31.9)
SF-36 Social functioning (0–100) 87.3 (21.2) 85.8 (21.6) 86.5 (21.4)
Neuroticism scale (0–12) 3.7 (3.2) 4.9 (3.3) 4.4 (3.3)
(Data are n (%), except for age, and SF-36 and neuroticism scales (mean (SD))).
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poorer SRH also rose especially in the presence of car-
diovascular diseases particularly where there was co-
morbidity with stroke or heart attack. Men with three or
more conditions had nearly two and a half times the risk
of poorer SRH than women, with the increase risk espe-
cially with multimorbidity involving stroke, heart attack
or diabetes.
A strong association was present between poor SRH
and poor psychosocial function, as shown in previous
studies [46,47]. In particular SRH has been shown to be
strongly associated with SF-36 mental health and social
functioning measures [48]. However, adjusting for psy-
chosocial measures did not significantly modify the asso-
ciation between chronic conditions, multimorbidity andSRH in this study. Only among those with stroke, was
there a slight weakening of the association with SRH
after controlling for psychological and social function-
ing. This may relate in part to the confounding effects
of poor cognitive function on psychosocial measures in
this population, which was not evaluated in this study.
Our findings, therefore, suggest that while psycho-
logical dysfunction and social deprivation and function-
ing are an important aspect of the multimorbidity
burden, they do not fully explain the association be-
tween physical multimorbidity and poorer subjective
health. The relationship between overall multimorbidity
burden and subjective health is likely to be determined
by a complex interaction of factors including physiological
interactions between diseases or the drugs used in their
Table 2 Self-rated health by demographic data, chronic conditions and number of conditions in 11,439 men in
EPIC-Norfolk
Total Excellent Good Moderate Poor
Age
39–64 7666 (67.0) 1444 (18.8) 4796 (62.6) 1278 (16.7) 148 (1.9)
>65 3773 (33.0) 537 (14.2) 2350 (62.3) 815 (21.6) 71 (1.9)
Social class
Manual 4670 (41.5) 584 (12.5) 2872 (61.5) 1096 (23.5) 118 (2.5)
Non-manual 6579 (58.5) 1359 (20.7) 4168 (63.4) 957 (14.5) 95 (1.4)
Chronic conditions
Cancer 426 (3.7) 48 (11.3) 260 (61.0) 104 (24.4) 14 (3.3)
Stroke 202 (1.8) 6 (3.0) 84 (41.6) 96 (47.5) 16 (7.9)
Heart attack 588 (5.1) 29 (4.9) 261 (44.4) 245 (41.7) 53 (9.0)
Diabetes 357 (3.1) 11 (3.1) 190 (53.2) 128 (35.9) 28 (7.8)
Arthritis 2619 (22.9) 430 (16.4) 1598 (61.0) 534 (20.4) 57 (2.2)
Respiratory (asthma or bronchitis) 1681 (14.7) 291 (17.3) 1068 (63.5) 293 (17.4) 29 (1.7)
Number of conditions
None 6694 (58.5) 1278 (19.1) 4289 (64.1) 1033 (15.4) 94 (1.4)
One 3739 (32.7) 593 (15.6) 2302 (61.6) 771 (20.6) 73 (2.0)
Two 896 (7.8) 108 (12.1) 509 (56.8) 244 (27.2) 35 (3.9)
Three or more 110 (1.0) 2 (1.8) 46 (41.8) 45 (40.9) 17 (15.5)
Psychological measures
Self-reported depression% 1509 (13.2) 260 (17.2) 932 (61.8) 287 (19.0) 30 (2.0)
Antidepressant use% 421 (3.7) 28 (6.7) 203 (48.2) 155 (36.8) 35 (8.3)
SF-36 Mental health(0–100) 79.0 (15.7) 84.6 (12.6) 80.2 (14.6) 70.2 (17.6) 62.9 (20.4)
SF-36 Role emotional(0–100 85.5 (30.3) 93.2 (20.4) 87.9 (27.6) 71.3 (39.8) 54.5 (45.4)
SF-36 Social functioning(0–100) 87.3 (21.2) 94.3 (14.4) 89.8 (18.5) 74.3 (26.0) 51.1 (32.7)
Neuroticism scale (0–12) 3.7 (3.2) 2.9 (2.7) 3.6 (3.1) 5.0 (3.4) 5.4 (3.6)
(Data are all n(%), except for SF-36 and neuroticism scales (mean (SD)).
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and treatment regimes and self-management [19,29,30,49].
Other studies have assessed the association of par-
ticular combinations of chronic conditions with SRH
[37]. In our study, analyses of the association of in-
creasing numbers of conditions added to a single index
condition helped identify those chronic conditions most
likely to contribute to morbidity burden in association with
other conditions. Our analysis included only combinations
of significant common chronic physical conditions. How-
ever, it suggests that particular combinations such as those
involving the cardiovascular system may potentially lead to
the greatest comorbidity burdens, independent of the pres-
ence of psychosocial factors. The relationships between dis-
ease burden and SRH especially in cases of multimorbidity
involving cardiovascular diseases were greater in men than
in women. Addressing poorer SRH in those with cardiovas-
cular disease in combination with other conditions may be
particularly important, since poor SRH has previously beenshown to be strongly associated with poor cardiovascular
outcomes [25].
Strengths and limitations
Strengths of this study include a large well-characterized
General Practice based population comparable to other
national samples in respect to both physical and psycho-
social characteristics [38,40,41]. Functional status, in
particular, is comparable to that documented for similar
age groups in two UK studies: The ‘Health Survey for
England’ and the ‘Omnibus Survey in Great Britain’ - al-
though the physical component summary scores in
EPIC-Norfolk are slightly lower compared to the Oxford
Health Life Survey [38,40,41]. Other strengths are that
common chronic diseases were studied, all except arth-
ritis being included in the English Quality Outcomes
Framework (QOF) [50]. Not all possible chronic condi-
tions, however, were included in the count of morbid-
ities. Our study reports an approximately 8% rate of
Table 3 Self-rated health by demographic data, chronic conditions and number of conditions in 13,829 women in
EPIC-Norfolk
Total Excellent Good Moderate Poor
Age
39–64 9642 (69.7) 1631 (16.9) 6215 (64.5) 1647 (17.1) 149 (1.5)
>65 4187 (30.3) 508 (12.1) 2620 (62.6) 966 (23.1) 93 (2.2
Social class
Manual 5195 (38.5) 607 (11.7) 3271 (63.0) 1198 (23.1) 119 (2.3)
Non-manual 8290 (61.5) 1477 (17.8) 5371 (64.8) 1329 (16.0) 113 (1.4)
Chronic conditions
Cancer 942 (6.8) 94 (10.0) 550 (58.4) 261 (27.7) 37 (3.9)
Stroke 140 (1.0) 9 (6.4) 73 (52.1) 45 (32.1) 13 (9.3)
Heart attack 178 (1.3) 5 (2.8) 77 (43.3) 76 (42.7) 20 (11.2)
Diabetes 214 (1.5) 8 (3.7) 111 (51.9) 79 (36.9) 16 (7.5)
Arthritis 3143 (22.7) 474 (15.1) 2015 (64.1) 608 (19.3) 46 (1.5)
Respiratory(asthma or bronchitis) 2163 (15.6) 312 (14.4) 1399 (64.7) 412 (19.0) 40 (1.8)
Number of conditions
None 8229 (59.5) 1370 (16.6) 5322 (64.7) 1420 (17.3) 117 (1.4)
One 4513 (32.6) 642 (14.2) 2852 (63.2) 932 (20.7) 87 (1.9)
Two 1003 (7.3) 121 (12.1) 615 (61.3) 236 (23.5) 31 (3.1)
Three or more 84 (0.6) 6 (7.1) 46 (54.8) 25 (29.8) 7 (8.3)
Psychological measures
Self-reported depression% 1987 (14.4) 336 (16.9) 1280 (64.4) 337 (17.0) 34 (1.7)
Antidepressant use% 965 (7.0) 57 (5.9) 511 (53.0) 336 (34.8) 61 (6.3)
SF-36 Mental health (0–100) 75.8 (16.4) 82.3 (13.7) 76.6 (15.4) 67.4 (17.8) 59.9 (28.1)
SF-36 Role emotional (0–100) 82.2 (32.9) 90.9 (23.3) 84.3 (30.9) 67.6 (40.9) 51.5 (45.6)
SF-36 Social functioning (0–100) 85.8 (21.6) 93.4 (15.2) 88.0 (19.4) 73.2 (26.0) 47.1 (28.1)
Neuroticism scale (0–12) 4.9 (3.3) 3.7 (2.9) 4.8 (3.2) 6.2 (3.3) 6.4 (3.5)
(Data are all n(%), except for SF-36 and neuroticism scales (mean (SD)).
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a recent systematic review by Violan et al. (2014), this is
lower than the lowest rate of multimorbidity reported in
any population (12.5% in a Dutch primary care cohort)
[5,51]. The reasons for this may include the use of only
five conditions in the count of multimorbidity, self-
report of conditions rather than reports derived from
medical records, and the fact that the oldest old were
not included in the study [52]. Self-report of doctor-
confirmed diagnoses were used in this study and may be
more sensitive to identifying symptoms-based conditions
[53], but may also lead to recall bias; for example those
with worse SRH may recall more diagnoses. The severity
and duration of conditions were not elicited in this
study. Reports were of having ever been diagnosed with
the condition, and therefore some conditions may have
not been currently limiting. Thus diagnosis of depression
which was not related to poorer subjective health, or
cancer which was weakly related, may be due to pastrather than current disease or ‘healthy survivor’ effect in
the case of cancer. Indeed current anti-depressant use
showed stronger association with poorer SRH than ever-
diagnosis of depression. The time gap between psycho-
logical measures and the remainder of the questions
elicited in the study may have reduced the association of
psychological measures with SRH. Socioeconomic mea-
sures in the EPIC-Norfolk were also limited to social
class and education. Time spent on health related activ-
ities is increased in the presence of multimorbidity and
may well mediate the association with SRH, but no in-
formation on this was available in our study [54]. Finally,
the cross-sectional design limits interpretation and poorer
subjective health may itself predict onset and severity of
multimorbidity.
Implications of findings
This study has implications for both primary care prac-
tice and future research. Primary care is central to
Table 4 Logistic regression models for “moderate/poor” compared to “good/excellent” SRH for chronic conditions and
psychosocial measures in EPIC-Norfolk
Men OR (95% CI) Women OR (95% CI) Combined* OR (95% CI)
Age (N = 11,439) (N = 13,829) (N = 25268)
>65 vs 39–64 1.3 (1.2–1.5) 1.5 (1.4–1.6) 1.4 (1.3–1.5)
Social Class (N = 11,249) (N = 13,485) (N = 24734)
Non-manual vs manual 0.5 (0.5–0.6) 0.6 (0.6–0.7) 0.6 (0.5–0.6)
Sex (N = 25268)
Female vs male - - 1.0 (1.0–1.1)
Psychosocial measures (N = 7619) (N = 9676) (N = 17295)
Diagnosis of depression (present vs absent)† 1.1 (0.9–1.2) 0.8 (0.8–1.0) 0.9 (0.9–1.0)
Antidepressant use (use vs no use)† 3.7 (3.0–4.5) 2.9 (2.6–3.4) 3.2 (2.8–3.5)
SF-36 Mental health (>80 vs. ≤80 )† 3.7 (3.2–4.2) 3.0 (2.7–3.4) 3.3 (3.0–3.6)
SF-36 Role Emotional (=100 vs. ≤99)† 3.1 (2.7–3.5) 2.8 (2.5–3.1) 2.9 (2.7–3.1)
SF-36 Social Functioning (=100 vs. ≤99)† 4.6 (4.1–5.5) 4.0 (3.5–4.4) 4.2 (3.9–4.6)
Neuroticism scale (<4 vs > =4)† 2.5 (2.2–2.8) 2.4 (2.1–2.6) 2.4 (2.2–2.6)
Chronic conditions (N = 11,439) (N = 13,829) (N = 25268)
Cancer† 1.5 (1.2–1.8) 1.8 (1.6–2.1) 1.7 (1.5–1.9)
Cancer adjusted‡ 1.3 (0.9–1.0) 1.8 (1.4–2.2) 1.6 (1.4–1.9)
Stroke† 4.5 (3.3–6.0) 2.4 (1.7–3.3) 3.4 (2.7–4.3)
Stroke adjusted‡ 3.1 (2.1–4.7) 1.6 (0.9–2.7)** 2.3 (1.7–3.2)
Heart attack† 4.1 (3.5–4.9) 3.8 (2.8–5.2) 4.0 (3.4–4.6)
Heart attack adjusted‡ 4.2 (3.3–5.3) 4.3 (2.9–6.5) 4.1 (3.4–5.1)
Diabetes† 2.9 (2.3–3.6) 2.9 (2.2–3.8) 2.9 (2.4–3.4)
Diabetes adjusted‡ 2.5 (1.9–3.4) 2.5 (1.7–3.7) 2.5 (2.0–3.2)
Arthritis† 1.2 (1.1–1.3) 1.0 (1.0–1.1) 1.1 (1.0–1.2)
Arthritis adjusted‡ 1.1 (1.0–1.3)** 1.0 (0.8–1.1)** 1.0 (0.9–1.1)**
Respiratory (asthma or bronchitis)† 0.9 (0.8–1.1) 1.1 (0.9–1.2) 1.0 (0.9–1.1)
Respiratory adjusted‡ 0.9 (0.8–1.1)** 1.2 (1.0–1.3) 1.1 (0.9–1.2)**
Multimorbidity (N = 11,439) (N = 13,829) (N = 25268)
None reported† Ref Ref Ref
None adjusted‡ Ref Ref Ref
One† 1.4 (1.3–1.6) 1.3 (1.2–1.4) 1.3 (1.2–1.4)
One adjusted‡ 1.4 (1.2–1.6) 1.3 (1.1–1.4) 1.3 (1.2–1.4)
Two conditions† 2.1 (1.8–2.5) 1.5 (1.3–1.8) 1.8 (1.6–2.0)
Two adjusted‡ 1.9 (1.5–2.3) 1.6 (1.3–2.0) 1.7 (1.5–2.0)
Three or more conditions† 5.8 (3.9–8.5) 2.2 (1.4–3.6) 3.8 (2.8–5.1)
Three adjusted‡ 5.2 (3.0–8.9) 2.1 (1.1–3.9) 3.4 (2.3–5.1)
†Adjusted for age and social class ‡adjusted for age and social class and psychosocial measures (depression, antidepressant use, SF-36 mental and social
functioning, neuroticism scale), *also adjusted for sex. All adjusted OR’s significant at p<.05 except those marked**.
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http://www.biomedcentral.com/1471-2296/15/185providing patient-centred care for patients with chronic
illnesses and multimorbidity. Tools for enabling care of
patients with multiple chronic conditions already include
multimorbidity registers, chronic condition clinics, guide-
lines for management of comorbid conditions, monitoring
coordination of care, and improving self-care and patienteducation [49,55]. Calls have also been made to screen for
depression for those with multiple chronic conditions in
primary care [56]. Similarly, SRH elicited from patients at
registration or review, at the beginning of consultations
verbally or in written form would contribute to these
tools. Eliciting SRH, especially among those with a history
Table 5 Univariate logisitic regression models for “moderate/poor” compared to “good/excellent” SRH for disease
combinations in EPIC-Norfolk
Men Women Combined *
Disease combinations N OR (95% CI) Ref = no
disease
N OR (95% CI) Ref = no
disease
N OR (95% CI) Ref = no
disease
Cancer
Cancer only † 249 1.5 (1.1–2.1) 578 1.9 (1.6–2.3) 827 1.8 (1.5–2.1)
Cancer adjusted ‡ 1.5 (1.1–2.1) 1.9 (1.6–2.3) 1.8 (1.5–2.1)
Cancer + one condition † 132 1.8 (1.2–2.6) 309 2.1 (1.6–2.7) 441 2.0 (1.6–2.4)
Cancer + one adjusted ‡ 1.8 (1.2–2.6) 2.0 (1.6–2.6) 2.0 (1.6–2.4)
Cancer + two or more conditions † 45 3.9 (2.1–7.1) 55 1.8 (1.0–3.3) 100 2.6 (1.7–3.9)
Cancer + two adjusted ‡ 3.9 (2.1–7.2) 1.8 (1.0–3.3) 2.6 (1.7–3.9)
Stroke
Stroke only † 101 4.3 (2.8–6.5) 70 2.9 (1.8–4.8) 171 3.6 (2.6–5.0)
Stroke adjusted ‡ 4.2 (2.8–6.3) 2.9 (1.7–4.8) 3.5 (2.6–4.9)
Stroke + one condition † 73 5.4 (3.4–8.8) 54 2.1 (1.2–3.7) 127 3.6 (2.5–5.2)
Stroke + one condition adjusted ‡ 5.4 (3.3–8.8) 2.0 (1.1–3.7) 3.6 (2.5–5.2)
Stroke + two or more conditions † 28 13.1 (5.5–31.1) 16 4.3 (1.5–11.9) 44 8.4 (4.4–16.1)
Stroke + two or more conditions adjusted ‡ 13.0 (5.4–31.1) 4.8 (1.7–13.3) 8.7 (4.6–16.7)
Heart attack
Heart attack only † 319 4.1 (3.2–5.2) 96 3.5 (2.3–5.3) 415 3.9 (3.2–4.8)
Heart attack only adjusted ‡ 4.1 (3.2–5.2) 3.5 (2.3–5.4) 3.9 (3.2–4.8)
Heart attack + one condition † 206 4.5 (3.3–6.0) 62 5.8 (3.4–10.0) 268 4.6 (3.6–-6.0)
Heart attack + one condition adjusted ‡ 4.4 (3.3–5.9) 6.0 (3.5–10.4) 4.6 (3.6–6.0)
Heart attack + two or more conditions † 63 10.3 (5.9–17.8) 20 4.4 (1.7–11.4) 83 8.3 (5.2–13.3)
Heart attack + two or more conditions
adjusted ‡
10.3 (5.9–18.0) 4.7 (1.8–12.2) 8.5 (5.3–13.6)
Diabetes
Diabetes only † 177 2.5 (1.8–3.4) 112 3.4 (2.3–5.0) 289 2.8 (2.2–3.6)
Diabetes only adjusted ‡ 2.5 (1.8–3.4) 3.4 (2.0–5.1) 2.8 (2.2–3.6)
Diabetes + one condition † 134 3.7 (2.6–5.3) 75 3.1 (2.0–5.0) 209 3.5 (2.6–4.6)
Diabetes + one condition adjusted ‡ 3.6 (2.5–5.2) 3.2 (2.0–5.1) 3.4 (2.6–4.6)
Diabetes + two or more conditions † 46 9.3 (5.0–17.4) 27 2.8 (1.3–6.3) 73 5.9 (3.7–9.5)
Diabetes + two or more conditions
adjusted ‡
9.4 (5.0–17.6) 2.4 (1.1–5.4) 5.7 (3.5–9.2)
Arthritis
Arthritis only † 1,854 1.2 (1.0–1.3) 2,265 1.1 (0.9–1.2) 4119 1.1 (1.0–1.2)
Arthritis only adjusted ‡ 1.2 (1.0–1.4) 1.1 (0.9–1.2)** 1.1 (1.0–1.2)
Arthritis + one condition † 678 1.8 (1.5–2.2) 805 1.3 (1.1–1.5) 1483 1.5 (1.3–1.7)
Arthritis + one condition adjusted ‡ 1.8 (1.5–2.2) 1.3 (1.1–1.5) 1.5 (1.3–1.7)
Arthritis + two or more conditions † 87 4.6 (3.0–7.2) 73 1.7 (1.0–2.9) 160 3.0 (2.1–4.1)
Arthritis + two or more conditions adjusted
‡
4.7 (3.0–7.2) 1.6 (1.0–2.7) 2.9 (2.1–4.0)
Respiratory (asthma or bronchitis)
Respiratory only † 1,039 0.9 (0.7–1.1) 1,392 1.1 (0.9–1.2) 2431 1.0 (0.9–1.1)
Respiratory only adjusted ‡ 0.9 (0.7–1.1)** 1.1 (0.9–1.3)** 1.0 (0.9–1.1)**
Respiratory + one condition † 569 1.4 (1.1–1.7) 701 1.2 (1.0–1.5) 1270 1.3 (1.1–1.5)
Respiratory + one condition adjusted ‡ 1.4 (1.1–1.7) 1.2 (1.0–1.5) 1.3 (1.1–1.5)
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Table 5 Univariate logisitic regression models for “moderate/poor” compared to “good/excellent” SRH for disease
combinations in EPIC-Norfolk (Continued)
Respiratory + two or more conditions † 73 4.0 (2.5–6.5) 70 2.2 (1.3–3.7) 143 3.0 (2.2–4.3)
Respiratory + two or more conditions
adjusted ‡
4.2 (2.6–6.7) 2.1 (1.3–3.6) 3.0 (2.1–4.3)
†Adjusted for age,social class ‡adjusted for age, social class and antidepressant use *adjusted also for sex. All adjusted OR’s significant at p<.05 except those
marked**.
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http://www.biomedcentral.com/1471-2296/15/185of three or more chronic diseases (in particular men) may
help to identify a group at risk of both poorer current
function and premature mortality, in particular when the
diagnosis involves a history of cardiovascular disease. A
recent study has shown improved outcomes including
health-related quality of life with a chronic disease self-
management programme, most frequently in those who
had multiple physical conditions plus ‘probable depres-
sion’ [56]. A similar approach could aim interventions
at those with multimorbidity who report poorer SRH.
Such interventions should focus on physical as well as
mental aspects of improving health status in patients
with multimorbidity.
The findings of this study raise questions for further
research especially the extent to which SRH fulfills the
criteria for screening for burden of illness in multimor-
bid states; longitudinal study is needed to confirm the
relationship between SRH and multimorbidity with better
characterisation of disease severity and psychological vul-
nerability. Development of studies to explore in greaterFigure 1 Univariate effect of specific disease combinations versus no
Models: Univariate effect of specific disease combinations* versus no diseas
social class and antidepressant use in 11,439 men and 13,829 women in EPdetail the subjective health of those with three or more
chronic conditions, specific combinations of conditions
associated with greatest illness burden, and to elicit fur-
ther information on what lies behind the significant rise in
subjective poorer health as numbers of conditions increase
would be of value. Exploration of discordant findings such
as factors associated with excellent SRH in the face of
multiple diagnoses may also be fruitful.
Conclusions
In conclusion, the reporting of poorer self-rated health
rises significantly in those with three or more chronic
conditions. Self-rated health provides an integrative
patient-centred assessment of multimorbidity burden,
over and above psychosocial measures, and should be
used in the evaluation and planning of care of patients
with multimorbidity in general practice. Further re-
search into the use of self-rated health as a screening
tool in general practice is required.disease on “poor” compared to “good” SRH. Logistic Regression
e on “poor” SRH compared to “good” SRH adjusted for age sex and
IC-Norfolk.
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